Clinical Trial Update: A Study of Avastin (Bevacizumab) With XELOX or FOLFOX in Patients With Metastatic Colorectal Cancer and Disease Progression Under First-line FOLFIRI and Avastin [Phase 2]

View source ↗

Summary

This is a Phase 2 trial update reporting results for Avastin (bevacizumab) combined with XELOX or FOLFOX in metastatic colorectal cancer patients who progressed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Adrucil (5-fluorouracil)
• Avastin (bevacizumab)
• Eloxatin (oxaliplatin)
• Wellcovorin (leucovorin calcium)
• Xeloda (capecitabine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-08-07